Cargando…
The Endothelin Type A Receptor as a Potential Therapeutic Target in Preeclampsia
Preeclampsia (PE) is a disorder of pregnancy typically characterized by new onset hypertension after gestational week 20 and proteinuria. Although PE is one of the leading causes of maternal and perinatal morbidity and death worldwide, the mechanisms of the pathogenesis of the disease remain unclear...
Autores principales: | Bakrania, Bhavisha, Duncan, Jeremy, Warrington, Junie P., Granger, Joey P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372538/ https://www.ncbi.nlm.nih.gov/pubmed/28264495 http://dx.doi.org/10.3390/ijms18030522 |
Ejemplares similares
-
Sustained Elevated Circulating Activin A Impairs Global Longitudinal Strain in Pregnant Rats: A Potential Mechanism for Preeclampsia-Related Cardiac Dysfunction
por: Bakrania, Bhavisha A., et al.
Publicado: (2022) -
Preeclampsia history and postpartum risk of cerebrovascular disease and cognitive impairment: Potential mechanisms
por: Beckett, Ashtin G., et al.
Publicado: (2023) -
Long‐Term Postpartum Cardiac Function and Its Association With Preeclampsia
por: deMartelly, Victoria A., et al.
Publicado: (2021) -
The angiotensin II type I receptor contributes to impaired cerebral blood flow autoregulation caused by placental ischemia in pregnant rats
por: Warrington, Junie P., et al.
Publicado: (2019) -
Role of 20-Hydroxyeicosatetraenoic Acid in Mediating Hypertension in Response to Chronic Renal Medullary Endothelin Type B Receptor Blockade
por: Speed, Joshua S., et al.
Publicado: (2011)